Polyamine profiles in tumor, normal tissue of the homologous breast, blood, and urine of breast cancer sufferers Jean LevêqueJean LevêqueJacques-Philippe Moulinoux OriginalPaper Pages: 99 - 105
T cell suppression as a mechanism for tolerance to MUC1 antigen in MUC1 transgenic mice Dongshu ChenShigeo KoidoJianlin Gong OriginalPaper Pages: 107 - 115
Cellular responses of mammary carcinomas to aromatase inhibitors: Effects of vorozole Konstantin ChristovAnne ShilkaitisRonald Lubet OriginalPaper Pages: 117 - 128
Anti-tumor immunity induced by Interleukin-12 gene therapy in a metastatic model of breast cancer is mediated by natural killer cells Celia M DivinoShu-Hsia ChenSavioLC Woo OriginalPaper Pages: 129 - 134
Microsatellite instability markers in breast cancer: A review and study showing MSI was not detected at ‘BAT 25’ and ‘BAT 26’ microsatellite markers in early-onset breast cancer Shoo Peng SiahShoo Peng SiahZbigniew Rudzki OriginalPaper Pages: 135 - 142
RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters Harriette J. KahnLu-Ying YangAlexander Marks OriginalPaper Pages: 143 - 151
β-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells Theodore A. SlotkinJian ZhangFrederic J. Seidler OriginalPaper Pages: 153 - 166
Eye problems in breast cancer patients treated with tamoxifen Annlia Paganini-HillLinda J Clark OriginalPaper Pages: 167 - 172
Analysis of cathepsin D in human breast cancer: Usefulness of the processsed 31 kDa active form of the enzyme as a prognostic indicator in node-negative and node-positive patients Lee B. RileyMarianne K. LangeJack A. Alhadeff OriginalPaper Pages: 173 - 179
EORTC 10941: A phase II study of liarozole in postmenopausal patients with ‘Chemotherapy-Resistant’ or ‘Potentially Hormone Sensitive’ metastatic breast cancer A. HamiltonJ.-A. RoyJ. Klijn OriginalPaper Pages: 181 - 188
